MFN2 Antikörper (AA 601-757)
Kurzübersicht für MFN2 Antikörper (AA 601-757) (ABIN3031819)
Target
Alle MFN2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 601-757
-
Aufreinigung
- Antigen affinity
-
Immunogen
- Human partial recombinant protein (AA 601-757) was used as the immunogen for this MFN2 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting amounts. Titration of the MFN2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 0.5-1 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- After reconstitution, the MFN2 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
-
-
- MFN2 (Mitofusin 2 (MFN2))
-
Andere Bezeichnung
- MFN2
-
Hintergrund
- Mitofusin-2 is a protein that in humans is encoded by the MFN2 gene. It is mapped to chromosome 1 and encodes a 757-amino acid protein that contains an ATP/GTP-binding site motif. This gene is expressed in many tissues and cell lines such as brain and KG-1 with the highest expression in heart and skeletal muscle. It has been found that MFN2 triggers mitochondrial energization, at least in part, by regulating OXPHOS expression through signals that are independent of its role as a mitochondrial fusion protein. And it contributes to the maintenance and operation of the mitochondrial network. Axonal CMT type 2A and autosomal dominant HMSN VI are caused by MFN2 and mutations of, which emphasizes its important role of mitochondrial function for both optic atrophies and peripheral neuropathies.
-
Gen-ID
- 9927
-
Pathways
- Skeletal Muscle Fiber Development
Target
-